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Summary 
Background and objective: Anaesthetic preconditioning exerts cardioprotective effects by 
reducing infarct size and improving recovery of contractile function after ischemia-
reperfusion. The interval between brief exposure to volatile anaesthetic and sustained 
ischemia, the acute memory phase, is dependent on intracellular signaling mediating this 
cardioprotection. Intramyocyte translocation of protein kinase C is known to be a key 
mediator in anaesthetic preconditioning. We examined the relationship between the time 
frame of the acute memory phase of sevoflurane preconditioning and intramyocyte 
translocation of protein kinase C-α, δ and ε to the particulate fraction. 
Methods: Isolated perfused guinea pig hearts were subjected to 30 min ischemia and 120 
min reperfusion. Anaesthetic preconditioning was elicited with one minimum alveolar 
concentration sevoflurane for 10 min. Washout times of 10, 30, 60, and 90 min were studied. 
Contractile recovery was assessed monitoring left ventricular developed pressures. Infarct 
size was determined by triphenyltetrazolium chloride staining. Translocation of protein 
kinase C was examined by Western blot analysis. 
Results: After ischemia-reperfusion, left ventricular developed pressure recovered to a 
greater degree with anaesthetic preconditioning compared with control for washout times of 
10 and 30 min, but not 60 and 90 min. Similarly, infarct size was reduced for washout times 
of 10 and 30 min, but not 60 and 90 min. Sustained translocation of protein kinase C-α and ε, 
but not δ, was associated with the time frame of the acute memory phase.  
Conclusions: The acute memory phase of sevoflurane preconditioning is limited to less than 
60 min. Sustained translocation of protein kinase C-α and ε, but not δ, correlate with this 
acute memory phase of sevoflurane preconditioning. 
 
Key Words: sevoflurane, myocardial preconditioning, protein kinase C 
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Introduction  
Anaesthetic preconditioning (APC) exerts cardioprotective effects by reducing infarct 
size and improving recovery of contractile function after ischemia-reperfusion [1-4]. The 
interval between brief exposure to volatile anaesthetic and sustained ischemia, the acute 
memory phase, is dependent on intracellular signaling mediating the APC cardioprotection. 
Beyond the acute memory phase, the beneficial effects of volatile anaesthetic against 
ischemia-reperfusion injury are lost. Kersten et al. [5] demonstrated that isoflurane produced 
an acute memory phase with a duration of at least 30 min in an in vivo dog study. In the same 
experimental setting, Toller et al. [6] reported that the acute memory phase of one minimum 
alveolar concentration (1 MAC) sevoflurane for 30 min disappeared by 30 min after 
discontinuation of sevoflurane. The time frame of the acute memory phase for sevoflurane 
APC in other animal models in not known.  
Protein kinase C (PKC) activation has been shown to be a pivotal signaling step in 
APC [7-9]. Sevoflurane APC is mediated by PKC-ε, but not δ, in isolated guinea pig hearts 
[10]. In contrast, translocation of PKC-δ, but not ε, to mitochondria has been shown to play a 
role in isoflurane APC [11]. Immunocytochemical analysis demonstrated that propofol 
translocates PKC-ε to intercalated discs and the sarcolemma, and PKC-δ to the perinuclear 
region in rat ventricular myocytes [12].  Although PKC appears to play a role in APC, the 
relationship between isoform-specific PKC translocation and the duration of the acute 
memory phase is not known. The purpose of this study was to identify the time frame of the 
acute memory phase of sevoflurane APC in isolated guinea pig hearts. Further, the 
relationship between PKC isoform (α, δ and ε) translocation and the duration of the 
sevoflurane APC acute memory phase was studied. As volatile anaesthetics can be 
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administrated with relatively low toxicity, elucidating the signaling mechanisms underlying 
APC may prove clinically useful during cardiac and non-cardiac surgeries [13-15]. 
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 Methods 
This study was conducted in accordance with the Guidelines for Animals Research at 
Osaka Dental University (ODU), and with the approval of the Animal Experiment 
Committee of ODU, Osaka, Japan. Male Hartley guinea pigs were fed Lab Diet (RC4TM, 
Oriental Yeast, Tokyo, Japan) and given water ad libitum.   
 
Isolated Heart Perfusion and Measurement of Function 
Animals weighing 650-700g were given heparin (1000 units i.p.), then anaesthetized 
with pentobarbital (60 mg kg-1 i.p.). Hearts were excised and immediately arrested in cold 
isosmotic saline containing 20 mmol L-1 KCl. Aortas were cannulated and the isolated hearts 
were retrogradely perfused at 70 mmHg on a nonrecirculating isovolumic perfused heart 
apparatus, using a Krebs-Henseleit (KH) perfusate (mmol L-1): 118 NaCl, 4.0 KCl, 2.52 
CaCl2, 24.8 NaHCO3, 1.7 MgSO4, 1.2 KH2PO4, 11.0 glucose, 0.5 EDTA and 8 units L-1 
insulin. The perfusate was insufflated continuously with O2 95% and CO2 5%. Hearts were 
paced at 240 beats min-1 using platinum-tipped electrodes connected to a Grass Instruments 
(Quincy, MA, USA) SD-5 stimulus generator. Left ventricular developed pressure (LVDP) 
was measured from a 2.5 French, mikro-tip® catheter transducer (SPR-524; Millar 
Instruments. Inc., Houston, TX, USA) passed into a compliant latex balloon inserted into the 
LV, and recorded on a PowerLab 2/20 Data Recording System (ADInstruments, Hayward, 
Australia). The balloon was connected to a Y-adapter with one end used to advance the 
micromanometer and the other used to fill the LV balloon with bubble-free water to an end-
diastolic pressure (LVEDP) of 10 mmHg. The maximum rate of increase of LV pressure 
(+dP/dtmax) and the minimum rate of decrease of LV pressure (-dP/dtmin) were calculated 
using ChartTM5 (ADInstruments). Coronary flow (CF) was measured by collecting effluent. 
Global ischemia was achieved by clamping the aortic inflow line. Heart temperature was 
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continuously monitored by a digital thermometer (PTW-100A, Unique Medical, Japan). 
During ischemia, hearts were maintained at 37 °C by enclosure in a water-jacketed air 
chamber. Warmed perfusate kept in the lower part of the chamber saturated the air with 
humidity and prevented cooling by evaporation. 
 
Experimental Protocol 
Animals were assigned 7 groups (n=8 each; Figure 1). All hearts were subjected to 
30 min and 120 min of reperfusion. After a 30 min equilibration, baseline LVDP, LVEDP 
and CF were recorded. Sevoflurane (1MAC; 2%) was insufflated by passing O2 95% and 
CO2 5% gas mixture for 10 min through a calibrated vaporizer (ACOMA, Tokyo, Japan). 
Coronary perfusate samples were collected anaerobically from the aortic cannula to measure 
sevoflurane concentration with an organic vapor sensor (OSP, Saitama, Japan). To define the 
limits of the acute memory phase of 1 MAC sevoflurane APC, washout times of 10 min (10 
MIN), 30 min (30 MIN), 60 min (60 MIN) and 90 min (90 MIN) were studied. To examine 
the role of PKC during the acute memory phase, the PKC inhibitor chelerythrine (10µM, 
Alexis-Calbiochemicals, Tokyo, Japan), was administered for 20 min, starting 10 min before 
sevoflurane exposure in 30 MIN (30 MIN+CHE). Chelerythrine was dissolved in distilled 
water, and added to the KH perfusate to a final concentration of 10 µM. 
 
Determination of Myocardial Infarct Size 
Infarct size was determined as previously described [8]. Briefly, at the end of 
experiments, the hearts were quickly frozen and sliced into 2 mm thick transverse sections. 
Each slice was incubated with 1% triphenyltetrazolium chloride (Sigma Chemicals) and was 
digitally photographed and the necrotic area was determined using Adobe Photoshop® CS 
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(Adobe, CA, USA), then expressed as a fraction of left ventricle.   
 
Western Blot Analysis 
     Translocation of PKC isoforms in response to preconditioning was assessed by 
Western Blot analysis. Myocardial tissue samples were collected before ischemia (n=4 in each 
group), and homogenized in TEE buffer (50 mM Tris-HCl, 5 mM EDTA, 10 mM EGTA, 0.3% 
β-mercaptoethanol, and 50 µg ml-1 PMSF, pH 7.5). Homogenate was centrifuged at 1,000g 
and 4 °C for 5 min. Supernatants were re-centrifuged at 10,000g and 4 °C for 15 min. 
Homogenates were centrifuged at 100,000g for 60 min and the supernatant was frozen at -
80°C (cytosolic fraction). Pellets were resuspended in TEET buffer (TEE buffer with 0.2% 
Triton X-100), incubated for 60 min and centrifuged at 100,000g for 60min (particulate 
fraction). Protein concentrations were estimated with a Bradford assay. Equivalent amounts 
(50 µg) of protein samples were loaded and separated on a 7.5 % SDS-PAGE gel, then 
electrically transferred to a PVDF membrane (Millipore Co., Billerica, USA). After blocking 
with 5% skim milk in Tris-buffered saline containing 0.1% Tween-20 (TBS-T),  membranes 
were incubated for 2 hr at 4 °C in TBS-T containing 5% milk and 1:1000 dilution of rabbit 
polyclonal antibodies for PKC-α and PKC-ε, and PKC-δ (C-20, C-15, and C-20, Santa Cruz 
Biotechnology, USA). Membranes were incubated with a 1:1000 dilution of horseradish 
peroxidase–labeled anti-rabbit immunoglobulin G (NA 934V, GE Healthcare, UK). Bound 
antibody signals were detected with enhanced chemiluminescence (Pierce Biotechnology, IL, 
USA) and visualized using VersaDoc 5000® Imaging System (Bio-Rad). Quantitative analysis 
of the band densities was performed by Quantity One® software (Bio-Rad).  
 
Statistics 
All data are expressed as mean±SD. Two-factor repeated-measures analysis of 
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variance was used to evaluate differences over time between groups. If differences were 
observed, a Tukey post-hoc test was used to confirm the significance of differences between 
groups. The differences in expressions of PKC cytosolic and particulate fractions were 
determined by unpaired Student’s t test. A value of p<0.05 was considered statistically 
significant. 
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Results 
The concentration of sevoflurane in the coronary perfusate after 10 min of exposure 
was 0.41±0.08 mM. Sevoflurane was not detected in the effluent during the baseline, 
ischemic, and reperfusion periods.  
 
Hemodynamics   
Baseline and pre-ischemia LVDP, LVEDP, +dP/dtmax, -dP/dtmin and CF were similar 
among the 7 groups (Table 1). Recovery of LVDP and LVEDP was significantly greater 
throughout reperfusion in 10 MIN and 30 MIN, but not 60 MIN and 90 MIN, when 
compared with control (CTL). Recovery of LVDP and LVEDP in 30 MIN was abolished by 
administration of CHE. Although CF significantly decreased after ischemia-reperfusion 
compared to baseline in all groups, the difference was only statistically significant in 60 
MIN, 90 MIN and 30 MIN+CHE (p<0.05). Nevertheless, there was no significant difference 
in CF among all groups throughout the experiment at each time point. This suggests that 
changes in CF do not account for the improved contractile recovery of 10 MIN and 30 MIN. 
Recovery of +dP/dtmax and -dP/dtmin was significantly greater throughout reperfusion 
in 10 MIN and 30 MIN, but not in 60 MIN and 90 MIN, when compared with CTL (Table 1).  
 
Myocardial Infarct Size 
After ischemia-reperfusion, infarct size was significantly reduced by APC compared 
with CTL for washout times of 10 and 30 min (10 MIN:21±7%, 30 MIN:25±10% vs. 
CTL:42±5%, p<0.05), but not 60 and 90 min (60 MIN:37±9%, 90 MIN:41±12%, p=NS vs. 
CTL). This cardioprotective effect was abolished by CHE (30 MIN+CHE:46±13%, p=NS vs. 
CTL). CHE treatment alone did not affect infarct size (CTL+CHE:47±10%) (Figure 2).   
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Western Blot analysis 
  The densities of cytosolic and particulate fractions of PKC-α, ε and δ were 
normalized against the corresponding densities of CTL (Figure 3). After sevoflurane 
exposure, PKC-α and ε, but not δ were translocated to the particulate fraction until 30 min, 
but not 60 and 90 min. Chelerythrine abolished this translocation of PKC-α and ε in 
30MIN+CHE. 
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Discussion 
The present study defined for the first time the duration of the acute memory phase of 
sevoflurane APC and its relationship to intramyocyte translocation of PKC isoforms in the 
isolated guinea pig heart model. Sevoflurane APC protects against ischemia-reperfusion 
injury, but this cardioprotective effect is restricted to an acute memory phase of less than 60 
min. Sustained translocation of PKC-α and ε, but not δ, to the particulate fraction is 
associated with this protective time frame. The PKC inhibitor, chelerythrine, inhibited both 
the sevoflurane-induced reduction in infarct size and translocation of PKC-α and ε. This 
suggests that translocation of PKC-α and ε mediates the acute memory phase of sevoflurane 
APC.  
In acute ischemic preconditioning, the infarct size limiting effect is lost if the 
memory phase is prolonged beyond 1 hr in pigs [16], and 1-2 hr in rabbits [17] or dogs [18]. 
In APC, Toller et al. reported that the acute memory phase of 1 MAC sevoflurane for 30 min 
disappeared by 30 min after discontinuation in an in vivo dog model [6]. In contrast, 1 MAC 
isoflurane has been shown to exert APC after the 30-min washout period in the same dog 
model [5]. The present study demonstrates that the acute memory phase associated with 
sevoflurane APC is present for greater than 30 min in guinea pig hearts. 
Translocation of PKC isoforms has been implicated in APC, as well as ischemic and 
ethanol-induced preconditioning [7,8,19-21]. Upon activation, PKC isoforms translocate to 
different subcellular components in the myocyte where they bind to anchoring molecules 
termed receptors for activated C kinase (RACKs) [22]. Isoform-selective RACKs are located 
on a variety of subcellular structures, including membranes and cytoskeletal elements. After 
binding to their selective RACKs, activated PKC isoforms phosphorylate protein substrates 
which propagate the preconditioning cardioprotective signaling cascade. Using isoform-
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specific inhibitors, Novalija et al. [10] demonstrated that sevoflurane APC preconditioning is 
mediated by PKC-ε, but not δ, in isolated guinea pig hearts. However, it has been reported 
that PKC-δ, rather than PKC-ε, is involved in acute memory phase of isoflurane APC by 
modulating sarcolemmal KATP channels in rat cardiomyocytes [23]. In the present study, 
PKC-α and ε, but not δ, were found to play a role in the acute memory phase of sevoflurane 
APC in guinea pig hearts.  
Ischemic preconditioning was not observed in either PKC-ε and PKC-δ knockout 
mice [24,25]. This suggests that both PKC isoforms are required for ischemic 
preconditioning. Miyamae et al. [20] found that regular ethanol consumption induced 
chronic preconditioning that was associated with sustained intramyocyte translocation of 
PKC-ε, but not PKC-α or δ, in guinea pig. Inagaki et al. [26] demonstrated that the timing of 
activation of PKC-ε and PKC-δ affects cardioprotection by acute ethanol-induced 
preconditioning in mice. They reported that PKC-ε activation during ischemia is 
cardioprotective, whereas PKC-δ activation in the middle of reperfusion is detrimental. 
Further, they found that initial PKC-δ activation leads to subsequent PKC-ε activation 
through release of adenosine [26]. In an isolated rat heart model of isoflurane APC, PKC-δ 
translocation to mitochondria and phosphorylation during the acute memory phase may play 
a role in transferring APC signaling to mitochondrial KATP channels [11]. In the present study, 
APC-induced translocation of PKC-δ to the particulate fraction (which includes the 
mitochondrial fraction) before ischemia was not observed. This finding is in agreement with 
those of Novalija et al. They found that sevoflurane APC is mediated by PKC-ε, but not δ, in 
isolated guinea pig hearts. Differences in the importance of PKC isoforms in mediating 
preconditioning and its acute memory phase may be due to differences in the 
preconditioning stimulus or species studied. 
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Recently, PKC-α has been found to play a role in sevoflurane APC through 
translocation to mitochondria in rat trabecula [27]. Using immunofluorescent staining, this 
study demonstrated that 3.8 % sevoflurane exposure for 15 min with 15 min washout 
translocated PKC-α to mitochondria. Further, PKC-α translocation was dependent on 
reactive oxygen species. The present study demonstrates that inhibition of PKC-α 
translocation by CHE during the acute memory phase abolished sevoflurane APC 
cardioprotection. This suggests that PKC-α may play a role in sevoflurane APC and its acute 
memory phase.  
 The following study limitations should be acknowledged. We did not directly measure 
PKC activity. The extent and duration of PKC redistribution determined by Western blot 
analysis may not truly reflect the amount of PKC activity which is more accurately 
determined after subcellular fractionation of the cell [28]. In addition, the methodology of 
our study does not allow us to make a definite link between the time frame of 
cardioprotection and translocation of PKC isoforms. The dose of CHE used in the present 
study has been previously found to abolish PKC activity [20]. CHE abolished both 
improvement of contractile dysfunction after ischemia-reperfusion and translocation of 
PKC-α and ε, but it is unclear which isoform plays a more important role in this acute 
memory phase, as CHE is not isoform-specific.  
In conclusion, the acute memory phase of sevoflurane APC is lost between 30 min 
and 60 min after sevoflurane exposure in an isolated guinea pig heart model. Sustained 
intramyocyte translocation of PKC-α and ε, but not δ, to the particulate fraction plays a role 
in mediating this sustained cardioprotection.  
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Table Legend 
Table 1: Data are presented as mean ± SD. LVDP=left ventricular developed pressure; 
LVEDP=left ventricular end-diastolic pressure; CF=coronary flow; +dP/dt
max=
maximum 
rate of increase of LV pressure; -dP/dt
min= maximum rate of increase of LV pressure; 
CTL=control; SEVO=sevoflurane; CHE=chelerythrine; *p<0.05 vs. CTL, n=8 for each 
group 
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                                                       Figure Legends 
Figure 1: Schematic illustration of the experimental protocol of this study.  All hearts were 
subjected to 30 min global ischemia followed by 120 min reperfusion. Anaesthetic 
preconditioning was elicited by administration of sevoflurane (2% or 1 MAC) for 10 min 
before ischemia. To determine the critical limits of efficacy of APC in this model, washout 
times of 10, 30, 60, and 90 min were studied (10 MIN, 30MIN, 60MIN, 90MIN). PKC 
inhibitor, chelerythrine (10µM) was administered for 20 min, starting 10 min before 
sevoflurane exposure in 30 MIN (30 MIN+CHE).  
 CTL=control; CHE=chelerythrine, a PKC inhibitor 
 
Figure 2: Infarct size as a percentage of left ventricle in 7 groups. After ischemia-reperfusion, 
infarct size was significantly reduced by APC compared with control for washout times of 10 
and 30 min, but not 60 and 90 min. This cardioprotective effect was abolished by CHE. CHE 
treatment alone did not affect infarct size. Closed circles: individual infarct size data points; 
open circles: mean infarct size; bars: mean ± SD. Data are presented as mean ± SD. *p<0.05 
vs. CTL 
 
Figure 3: Western blot analysis of PKC-α, ε, and δ from left ventricular samples before 
ischemia in control and sevoflurane-treated hearts (n=4 for each group). PKC-α and ε, but 
not δ, were translocated to the particulate fraction until 30 min, but not 60 and 90 min, after 
sevoflurane exposure. *p<0.05 vs. 10MIN cytosolic fraction, #p<0.05 vs. 30MIN cytosolic 
fraction, C=cytosolic fraction; P=particulate fraction 
 
